Read + Share
Zeidan AM, Borate U, Pollyea DA, Brunner AM, et al. A phase 1b study of venetoclax and azacitidine combination in patients with
relapsed or refractory myelodysplastic syndromes. Am J Hematol 2023;98:272-281.
PMID: 36309981
|
 |
|
Zeidan AM, Borate U, Pollyea DA, Brunner AM, et al. A phase 1b study of venetoclax and azacitidine combination in patients with
relapsed or refractory myelodysplastic syndromes. Am J Hematol 2023;98:272-281.
PMID: 36309981
|
|
|
|